Are we selling personalised medicine before its time?

We may be a long way off from using genetics to reliably gauge our risks for specific diseases, say researchers at the University of Pittsburgh Graduate School of Public Health in a study published on 5 February in the online journal PLoS Genetics. Yet, many companies currently offer personalised genetic testing for diseases like cancer, heart disease and diabetes, and tout the ability of DNA testing to predict future health risks...

Read the whole article on

More from